Kytopen

Biotechnology · Cell & Gene Therapy
Sponsors visas
6EmployeesUS Form 5500 (plan participants) · Dec 2025 · -54% in a year

Facts

as of Nov 17, 2026

Kytopen is accelerating access to the next generation of cell therapies through scalable genome engineering by solving manufacturing problems at discovery.

Legal name
Kytopen Corp.
Headquarters
Cambridge, United States
Founded
2017
Employees
6US Form 5500 (plan participants) · Dec 2025 · -54% in a year
Register numbers
NAME kytopen corp
Official records
SEC CIK 1777277
Website
kytopen.com

These are the key facts about Kytopen on Alion as of Nov 17, 2026. Kytopen is headquartered in Cambridge, United States. It was founded in 2017. It has raised $52.7M in 5 funding rounds. The latest round is Venture - Series Unknown of $7.1M, announced in 2025.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
Kytopen Corp.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Named in the work visa registers of United States.

0H-1B filings in 12 months
0Open roles in United States

In the register as Kytopen Corp, Cambridge, MA

Other sponsors in the same field
Alert me
US Department of Labor · latest filing Dec 26, 2024

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Cambridge United StatesHeadquarters0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$52.7MTotal raised
$3.1MPublic grants4 public grants
Venture - Series UnknownLatest round
9Rounds and grants
Money by yearUSD, rounds and grants
2025$7.1M1 record
2024$7.3M2 records
2021$32.8M2 records
2020$3.1M1 record
2019$5.3M2 records
2018$225k1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers

Milestones

Each milestone is dated by its source: registers, filings, the press

Newsroom

Apr 292026
News · YahooFinance
Kytopen Corp., a leader in non-viral, continuous flow cellular engineering technologies, T-CURX GmbH ("T-CURX"), a leader in transposon-based CAR-T manufacturing, and Fraunhofer…
Apr 102026
News · Pulse 2.0
Kytopen announced a Series B financing round led by Telegraph Hill Partners, with participation from existing investors, as the company accelerates commercialization of its cellu…
Nov 12, 20252025
News · YahooFinance
Kytopen Corp., a leader in continuous flow cellular engineering, and Excellos, Inc., a cell therapy CDMO and member of Blood Centers of America (BCA), today announced that the tw…
May 8, 20252025
News · YahooFinance
Kytopen Corp., a leader in providing continuous flow cellular engineering technologies and Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science re…
Apr 29, 20252025
News · YahooFinance
Kytopen Corp., a leader in providing non-viral, continuous flow cellular engineering technologies and Aldevron, a leading global manufacturer serving organizations in the gene ed…
Apr 28, 20252025
News · Nasdaq
(RTTNews) - Kytopen Corp., and Aldevron, a subsidiary of Danaher Corp. (DHR), Tuesday announced a collaboration to improve the workflow solutions for cell therapy manufacturers,…
Sources: the outlets named on each headline, each story once